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Summary.-A large-scale trial has been started in the United Kingdom with the aim
of evaluating the effectiveness of different methods for the early detection of breast
cancer. Two populations, each of 25,000 women aged 45-64 are invited for annual
screening by mammography and/or clinical examination. Two further populations,
one of25,000 and one of40,000 women in the same age range, are invited for education
sessions in breast self-examination, and 4 control populations, totalling 120,000
women, are offered no additional services beyond conventional diagnostic facilities.
All breast histology, both benign and malignant, in all women in the study is recorded,
as are the findings, management and follow-up of all breast cancers. Changes in the
populations, and deaths from all causes, are also recorded.
This is essentially a non-randomized trial, though in one of the screening centres,
where an education programme about breast cancer is provided for the whole
population, only women registered with certain randomly selected general practices
are invited to be screened. The principal means of evaluation will be the comparison
of the mortality rates from breast cancer in each of the study populations. Costs, in
terms of use of health resources, unnecessary surgery and radiation hazard, will be
assessed. Additional aspects of the trial include studies of women's attitudes to early
detection, and of the aetiology of breast cancer.
AMONG BRITISH WOMEN, breast cancer prevention, because the aetiology ofbreast
is the commonest malignant neoplasm, cancer, although obviously implicating
the commonest cause of cancer death and, endocrine factors and, possibly, diet, is
at ages 35-59 years, the commonest single still obscure (Kelsey, 1979). At the other
cause of death. Moreover, there is cause end of the scale, there are grounds for
for concern because both incidence and cautious optimism that chemotherapy or
mortality rates seem to be increasing hormonal therapy, adjuvant to primary
slightly (Office ofPopulation Censuses and surgical treatment, may, in some pre-
Surveys, 1971, 1974). There is little imme- menopausal women, improve survival
diate prospect of any method of primary rates, but this seems unlikely to nmake a
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sizeable impact on overall mortality
(Bonnadonna, 1980). The best hope of
controlling deaths from this disease in the
foreseeable future seems to lie in early
detection and treatment before systemic
spread has occurred. The reason for be-
lieving in early detection derives from
theoretical considerations and, principally,
from the results of a randomized con-
trolled trial of screening for breast cancer
conducted by Shapiro and his colleagues
in the Health Insurance Plan of Greater
New York (Shapiro, 1978). In this study,
62,000 women between the ages of 40 and
60 years were randomly divided into a
study group, offered annual screening for
4 years, and a control group who were not
offered screening. Ten years after entering
the trial there had been 97 deaths from
breast cancer in the study group (less than
half of whom participated in all 4 screens)
and 137 in the control group. The defici-
ency did not affect all groups equally;
there was no difference in mortality at
40-49 years, but a large difference
(P < 0.01) in women aged 50-59 years and
a lesser difference in women aged 60 years
and over. Shapiro's study is an excellent
example of the kind of trial required to
evaluate health services, and provides the
only satisfactory evidence so far of the
benefit of screening. However, the mam-
mography techniques used are now out of
date, it was on a relatively small scale, and
it leaves unanswered some ofthe questions
relevant to drawing up a balance-sheet of
present-day benefits and costs resulting
from different policies of early detection.
The present "Trial of Early Detection of
Breast Cancer" was therefore set up, not
only to confirm or refute the evidence on
effectiveness of screening, but also to
address itself to the public health issue of
how much good can be done by early-
detection measures applied to a British
community and at what cost.
The trial is seeking to demonstrate
whether, in a typical population ofmiddle-
aged women, a reduction in mortality can
be achieved of sufficient size to justify the
cost ofintroducing early-detection services
into the health service. It is concerned
with evaluation, not only of screening by
professionally trained staff, but also of
education in breast self-examination. The
latter technique is widely advocated but
has received little critical study. Nothing
is known of its effectiveness in reducing
mortality, and very little is known of its
potential disadvantages, which may in-
clude provocation of anxiety and the per-
formance of unnecessary biopsies. Al-
though, on the face of it, it would seem to
be much less expensive than screening, its
resource implications have not been
assessed.
The principal aim of this trial is to
measure mortality from breast cancer over
a period of several years in populations of
middle-aged women who have been
offered different services for the diagnosis
of breast cancer. Subsidiary aims are to
compare survival rates of women with
breast cancer diagnosed by different
methods, to measure the sensitivity and
specificity of different detection methods,
to study the natural history ofearly breast
cancer, particularly in relation to pre-
invasive lesions, to assess women's reac-
tions to early-detection programmes and
how these affect their compliance, and to
measure the resource implications of the
early-detection programmes.
PLANNING OF THE TRIAL
A working group was set up by the
Department of Health & Social Security
to consider how early detection of breast
cancer might be evaluated within the
National Health Service. The group
accepted that with their remit, which
excluded the possibility of repeating a
controlled trial of the sort conducted by
Shapiro and his colleagues, it would be
necessary to measure and compare the
impact of screening and self-examination
policies applied to typical populations of
women. It was agreed that health districts
would provide populations of appropriate
size. The age group 45-64 years at the
start of the trial was chosen as that in
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which early detection was likely to be most
effective. Although the group would have
preferred to include women down to the
age of 40, financial constraints prevented
this; because of the lower incidence in
younger women, the returns in terms of
cases detected would be less, and the
population required to demonstrate anv
effect ofearly detection accordingly larger.
The working group also considered that a
convincing answer would be much more
likely and more credible if there was
replication ofthe studies both ofscreening
and self-examination, in order to assess the
external validity of the findings (Patrick,
1980).
Health districts were therefore inivited
to submit protocols either for a plan to
offer screening to all women aged 45-64
years annually for 7 years, or a plan
attempting to educate all women within
the same age range to undertake regular
breast self-examination. From the proto-
cols submitted 4 districts were chosen, 2
being "screening centres" and 2 "self-
examination centres". Four "comparison
centres" were also asked to participate,
these being representative of good current
practice in the diagnosis and treatment of
breast cancer, but without any specific
early-detection programme. The purpose
of these is to provide additional informa-
tion against which changes in incidence
and mortality in the early-detection
centres can be gauged.
The approximate number of women in
each centre at the start of the trial is
shown in Table I. The fieldwork is sched-
uled to continue for 7 years, and it is
hoped that follow-up can be extended for
longer. In one of the screening centres,
(A), a city with 65,000 women in the
age group, an education campaign aiming
to improve knowledge about breast cancer
and to encourage breast self-examination
is being conducted through media pub-
licity and meetings held for women's
organizations and in places of work. A
random sample of 45% of general prac-
tices in the city has been selected and only
women on these practice lists are being
invited for screening. Breast-cancer inci-
dence and mortality are being monitored
in both the screening group and the re-
mainder. Thus in this centre it has been
possible to use a method of random
selection of a population for screening, in
the context of a larger population who are
receiving education. In one of the self-
examination centres (D), also in an urban
area, the main education campaign will
concentrate on personal invitations to
group teaching sessions for 35,000 women
in one health district, while a general
media, leaflet and meetings campaign will
be launched in the city's other health dis-
trict. This centre will thus provide some
information on the relative effectiveness of
alternative methods of self-examination
education, though the allocation to differ-
ent methods is not randomized.
BASIC INFORAIATION FROM
EACH CENTRE
In all 8 districts, a basic set of informa-
tion is required in order to achieve valid
comparisons between their rates of breast
cancer. This necessitates accurate record-
ing of the population of women, so that
the denominators used for calculating
rates are appropriate; and complete re-
cording of all breast cancers and breast-
cancer deaths in these women, for the
numerators. It is particularly important
in the early-detection districts to ensure
that all breast cancers are included, not
merely those detected by screening or
self-examination, in order to ensure com-
parability of cancer incidence and mort-
ality between early-detection centres and
comparison centres. The basic core of in-
formation is summarized in the Figure.
Defining the population
A register of all women between the
ages of 45-64 has been compiled from the
lists of all general practitioners serving
each district. The register is regularly
updated to record any women who leave
and any women within the age group who
join one of these practices. Women who
attain the age of 45 during the trial period
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New entrants
over 7-year
period
Defined Deaths from all
population of
causes over
women aged 7-year period
45-64 in
1979-80
Leavers over
\s 7-year period
flagged
for cancer
All registrations
breast histology and deaths
Clinical findings
and management
of breast cancer
Annual
follow-up of all
breast cancer
patients
FIGURE-. Sllummary of core itiformationi (ol-
le(ted( frorn all ceiitIres.
will be added. At the upper end of the age
range, women will continue in the trial
population until it ends, at which time the
oldest woman will be aged 72. It is esti-
mated from 1971 census information that
, 3O of the population aged 45-64 years
move to a different area each year. In
order that relevant information about
women who move should not be lost, their
records at the NHS Central Register are
flagged, and subsequent cancer registra-
tions or deaths occurring in these women
are notified to the trial coordinator. Thus
it will be possible to analyse results both
in the cohort of women identified at the
start and by annual cross-sectional com-
parisons within age groups.
Incidence ofbreast disease
In this context breast disease is defined
as any lesion which is biopsied and re-
ferred for histology. In each centre a
register of all breast histology in trial
women has been set up. This is done by
regularly scanning the day-books of all
histopathology laboratories likely to re-
ceive specimens from the trial population.
Details are noted of any woman within
the age range who has had a biopsy, and
these are subsequently matched against
the local register to check whether she is
included in the population. If she is, the
pathologist is asked to complete a form
recording details of the histology. Thus a
record of both benign and malignant
lesions is obtained. The purpose of record-
ing benign lesions as well as malignant is
to enable comparisons of the overall
biopsy rates in the different districts and
of the distribution of lesions within them.
The histology record for malignant cases
includes type of carcinoma and evidence
of involvement of lymph nodes. An addi-
tional check of radiotherapy records and
cancer registrations is made, to pick up
any cancers for whom histology is not
available.
Management ofbreast cancer
Although most of the centres have
established breast units, there is no
guarantee that all women with breast
cancer will be treated by one surgical
team and, particularly in the urban dis-
tricts, a number of different surgeons may
be involved. No specific policy of man-
aging breast cancer has, therefore, been
laid down, but a detailed record is made
of the methods used in treating each case,
together with the history and clinical
findings. In the event that one particular
form of treatment should, during the
studyperiod, beshowntobe advantageous,
it should be possible to adjust for this in
analysing differences between the dis-
tricts. For every woman with breast
cancer, a check will be made at the
anniversary of her date of diagnosis to
determine whether she is alive and if she
has had any recurrence.
MORTALITY
Date and cause of all deaths among
women in the trial are recorded. This pro-
vides an additional check on breast-
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cancer deaths arnd also enables comparison
ofthe health ofthe districts in other ways.
The source of information is the Regis-
trar's list of deaths provided weekly for
each health district in England (this in-
cludes residents who died outside the
districts concerned) and the quarterly
lists similarly provided by the Scottish
General Register Office. These lists are
scanned and particulars of any woman in
the trial age group who has died are
matched against the population register.
ADDITIONAL PROCEDURES
FOLLOWED IN EACII CENTRE
Screening centres
In the 2 screening centres, clinical ex-
amination of the breast is offered every
year for 7 years, with mammography in
Years 1, 3, 5 and 7. Each woman is per-
sonally invited in a letter sent out froni
the screening clinic, with a covering letter
from her general practitioner encouraging
her to take part. The initial invitations
are spread over a 2-year period, each
woman being allocated a date of entry to
the trial when she is first invited (regard-
less of whether she accepts). WVomen who
are excluded by their GP are not invited,
but are giveni a date of entry; those who
positively refuse to participate are not,
approached again, btut retain their date of
entry. Both these grouips are still included
in the basic population in order to pre-
serve comparability with the comparisoni
centres and ensure that any subsequent
breast biopsies are detected through the
histopathology laboratories.
WAhen ac woman attends for screening,
she is examined clinically and has mammo-
grams taken of each breast. In Centre B,
the mammography technique is the single
oblique view developed by Lundgren
(1979), wvhile in A obliquie anid cephalo-
caudal views are taken. In B the mammo-
grams are read by the same doctor who
performs the clinical examination; the
decision to use the same observer was
based on earlier work (Chamberlain et al.,
1979) which concluded that both clinical
examiriation acnd rlrammography were
necessary to achieve a sensitivity of 75%.
Moreover it was felt that there might be a
considerable gain in sensitivity by com-
bining vague suspicions by the same
observer on each modality, each of which
on their own might be regarded as in-
sufficient, grotunds for referral. In Centre A
the results of clinical examination (which
is performed by specially trained nurses)
and of mammography (which is read by
doctors) are recorded independently, so
that it will be possible to measure their
independent contributions to cancer de-
tection. In both centres, women in whom
either a clinical or mammographic ab-
normality is suspected are normally re-
ferred for review by more experienced
staff. (Exceptionally, they may be referred
direct to hospital.) After any minor pro-
cedures sutch as cyst aspiration, a decision
is made on whether or not biopsy is
needed and, if necessary, appropriate
arrangements for hospital referral are
made with the consent ofthe woman's GP.
In both districts in the 2nd, 4th and
6th years screening will consist only of
clinical examination performed by nurses,
with the referral procedure as already
described.
Self-exantination centres
The aim in self-examination centres is
to persuade women in the trial population
t,o undertake regular monthly self-examin-
ation, uising the correct technique, and to
report immediately any abnormalities.
This is one of the most, difficult topics in
health education because it raises emo-
tional issues such as the curability of
cancer, fear of mastectomy and the sexual
connotations of the breast, which many
women may prefer to suppress. Unlike
inany other health-education measures,
breast self-examination (BSE) offers no
perceptible immediate advantage, and the
recommended interval of one month
between examinations is longer than would
enable it to become an auitomatic habit.
Even if sufficient motivation to overcome
these disadvantages can be induced, there
I OEARLY DETECTION OF BREAST CANCER
remains the difficult responsibility for the
woman herself in deciding what is, or is
not, an abnormality worth reporting.
Possible methods ofeducating the popu-
lation include publicity in the media, dis-
tribution of leaflets, and provision of
teaching sessions with or without invita-
tions. Centres C and D chose personal
invitations to classes as their principal
method, backed up by some supporting
publicity in the media. Teaching sessions
have the advantage ofencouraging women
to discuss their questions and worries with
the teacher, enable a more precise demon-
stration of the technique of BSE, give
clear advice on what to do if an abnorm-
ality is found and can be directed at a
specific group ofwomen. Also, the possible
overloading of clinical services which
might result from a surge of media ad-
vertising can be avoided by successively
inviting women to attend classes and thus
staggering the spread of initial education
through the population.
In both self-examination centres, women
in the trial population are invited to
attend classes in a way comparable to the
inivitations to attend clinics in screening
districts; each woman is allocated a date
of entry when she is invited, regardless of
whether she accepts. In Centre C, classes
are held in local community halls with up
to 50 women attending each session. In
Centre D, the sessions are held in a
specially designated unit in the hospital,
and up to 25 women attend. In both
centres a record is kept ofthe attendances
so that response to the invitation is known.
The educational content is similar in both,
consisting of a talk about the normal
breast, the abnormalities that can occur
(with emphasis on the preponderance of
benign lesions), the importance of early
detection of cancer, the treatment and
curability of early cancer, the technique
of BSE demonstrated in a film, and pre-
cise instructions on what to do if an
abnormality is found. The teaching is all
done by nurses in Centre D, but a team of
nurses, health education research officer
and surgeon is used in Centre C.
Although the ultimate success of BSE
education will be judged by a fall in
mortality from breast cancer, as an inter-
mediate step it is also valuable to find out
women's reactions to it and the extent to
which they are complying. Since know-
ledge and public opinion about it are
likely to spread by informal communica-
tion channels, it is necessary to question
both attenders and non-attenders at
teaching sessions to find out how the
education has been received and the extent
to which it is practised. Sample surveys
to explore these aspects are being carried
out in both centres.
In each of the self-examination centres,
special clinics have been opened which
women suspecting abnormalities may
attend without going first to their general
practitioner. These offer clinical examina-
tion and mammography, the clinical ex-
amination being performed by the same
nurses that do the teaching, and mam-
mography being reported by radiologists.
Some women may prefer to consult their
general practitioner with any abnorm-
alities they find. In such cases the trial
will learn about them only if they are
referred for a biopsy, in which case they
will be identified in the histopathology
register.
Comparison centres
No additional services have been pro-
vided for the 4 comparison centres, be-
cause their function is to record the
results of management of breast cancer in
the conventional way. In each of them
extra clerical support is provided to main-
tain the register of women in the popu-
lation, and a research assistant is respons-
ible for ensuring that information on
women with breast disease is reported. All
women in the comparison centres at the
start of the trial are allocated the same
date of entry, midway through the 2-year
period of initial invitations in the early-
detection districts. Thereafter, new en-
trants are added once a year. As in the
screening and self-examination districts,
the pathologists concerned have agreed to
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report all breast histology, and the sur-
geons and radiotherapists have agreed to
record clinical information about patients
with breast cancer in a standard form.
I)ATA PROCESSING
A common recording system has been
agreed by all participating districts. This
covers not only the "core" information
listed in the Figure but also details of
women's attendances at clinics in the 4
early-detection districts, including clinical
and mammography findings. One copy of
each record is kept locally, in some cases
being put on computer file for local use. A
second copy, from which the woman's
name and address have been deleted, is
sent to the trial's coordinating centre.
Here it is checked, coded, punched and
put on computer tape for subsequent
central analysis using University of Lon-
don computing facilities, including the
data-base package at Queen Mary College,
London.
STATISTICAL ASPECTS
The trial is aiming to demonstrate
whether deaths from breast cancer can be
prevented by policies of screening or BSE
education and, if so, how many. Therefore
the most valid measure of outcome is a
conmparison of the rates of death from
breast cancer in the different populations
under study. Since information on certified
cause of death is being collected, breast-
cancer mortality rates are readily available
both for the early-detection centres and
for the comparison centres (including in
the latter, the women in Centres A and D
who are registered with practices which
are not invited for screening or education
respectively). Some of the deaths (a sub-
stantial proportion in the early years) will
be among women whose breast cancer was
diagnosed and treated before the start of
the trial. Therefore for each death in
whiclh breast cancer was certified as a
cause or contributory cause, the date of
diagnosis is determined, and those diag-
nosed before the women's date of entry to
the trial are excluded. Thus the mortalitv
analysis will refer to a cohort ofwomen in
whom breast cancer had not been diag-
nosed at the start of the trial.
Another method of assessing the impact
of the early-detection programmes is to
compare the survival rates of all breast
cancers diagnosed in the different popu-
lations during the course of the trial. This
analysis will also be done, bearing in mind
the biases due to lead-time and length-
biased sampling which are inherent in
survival comparisons of cancers diagnosed
by screening with those diagnosed by
svmptomatic presentation (Fenleib &
Zelen, 1969). The method whereby each
cancer was discovered is noted in every
case. As the incidence of breast cancer is
being accurately recorded in each centre
throughout the trial, it is hoped that an
estimate can be made of the extent of
these biases, and an appropriate adjust-
ment made (Shapiro et al., 1974).
An important issue confronting the
analysis of results is the quasi-experi-
mental nature of this trial, due to the fact
that, except in Centre A, randomization
of women to be offered or not offered the
early-detection measure was not per-
mitted. Centre A can be regarded as a true
experiment which could answer the ques-
tion "Does the addition of screening to a
population of women instructed in the
importance of early diagnosis and breast
self-examination reduce mortality from
breast cancer?" For the remaining popu-
lations, however, although it will be
possible to correct for a number of factors
which could influence mortality rates, the
possibility ofsystematic variation between
centres cannot be ruled out. This is made
less likely by the inclusion of the whole
population in each centre, thus eliminating
some of the biases of selection.
There are numerous examples ofpublic-
health measures the effectiveness of which
have been tested by non-randomized
comparisons betweengeographically separ-
ate populations, and by historical com-
parisons with the situation before the
measure was introduced (Patrick, 1980).
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TABLE I.- Ninber of women aged 45-64
r-eceiving different servicesfor detection of
breast cancer in the trial centres
TABLE II.-Mortality from breast cancer in
women aged 45-74 in the trial centres for
the period 1969-78
Ceintre
A
B
C
D
A'
D'
E
F
G
H
Personal
invitation
to
iscreening
30,000
24,000
Personal
invitation
to BSE
e(duication
:30,00()
45,000
General
BSE
e(lueation
:35,000
30,0()00
No special
policy for
eairly
(letection
25,000
45,000
30,000
50,000
A + A' an(d D + D' are cities in whiclh the popula-
tion of women in the trial is subdivided into those
receiving different levels of service.
General practices in Centre A are randomly
allocatedl to e(lutcation alone or education + screening.
The divisioin of City 1) is on a geographical basis
into its 2 component health (listricts.
Examples include fluoridation of water
(R. Coll. Physicians, 1975) and prevention
of ischaemic heart disease (Farquhar,
1978; Puska et al., 1979). Randomization
of individuals is statistically preferable
but frequently compromises have to be
made, such as limiting the study to
volunteer subjects who are willing to be
randomized (Gilbertson et al., 1980), or
offering the control subjects less of the
service being offered to the study group
(Rameharan et al., 1973). These solutions
may provide evidence of whether or not
the service can be effective, but do not tell
the extent of effect it will have in real life.
For preventive services, in particular
those involving health education, the ideal
unit to be studied is not the individual but
the community to which it will be applied
(Cornstock, 1978).
These points being borne in mind,
analysis will concentrate on measuring
differences in trends of breast-cancer
mortality after the start of the trial in the
populations shown in Table I. The mort-
ality rate in each of the 8 centres for the
period 1968-1979 (1978 for the 2 centres
in Scotland) has been studied using in-
formation obtained from OPCS and the
Scottish GRO. The number ofdeaths from
43
Centre
A + A'
B
C
D
E
F
G
H
Breast cancer
dleaths in
women age(l
45-74
819
298
340
584
244
614
296
740
* Rates are age-stan(lardize(l
Englandt an(l WVales for 1971.
Age-
stan(lardized*
rate per
100,000
women years
92-8
92-4
86-9
93 8
73-6
89 5
82-7
87-0
Using population of
breast cancer among women aged 45-74
(because measures applied to women aged
45-64 at the start of the trial can be ex-
pected to influence mortality at least up
to age 74), in 10-year age groups has been
obtained, and related to mid-year popu-
lation estimates. Both numbers of deaths
and population estimates have been ad-
justed where necessary to take into
account changes in the composition of the
health districts, in particular those due to
reorganization in 1974. For this period,
age-standardized mortality rates in the
different centres range between 73 and 100
deaths per 100,000 women-years, similar
to England and Wales as a whole, where
the rate increased from 84 per 100,000 in
1968 to 92 per 100,000 in 1978. There is,
however, some variation between the dis-
tricts (Table II).
Information on past trends in incidence
and survival has been sought from the
registries concerned, but there have been
substantial differences between them in
their completeness of registration and, in
some cases, a breakdown by health dis-
trict is impossible. This information is
therefore not sufficiently reliable to be
used to explain the variation in mortality
between the centres. Possible explanations
for the variation, such as differences in
distribution of risk factors or in histo-
logical type of cancer, will be further ex-
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plored using additional information col-
lected during the early years of the trial.
Despite the variation between districts
it is still possible to compare the effect of
the early-detection programmes on mort-
ality rates, provided that the populations
do not alter significantly during the study
in respect of factors related to this vari-
ation. The populations of wonmen included
in the trial are not selected in any way
within each centre, and complete and
accurate information on factors known to
influence breast-cancer mortality rates
(e.g. incidence, distribution of histological
type, therapy) is being prospectivelv
recorded.
In looking at mortality after the start of
the trial, deaths from breast cancer among
women diagnosed as having the disease
before their date of entry are excluded.
The expected number of deaths in the
remaining cohort of "initially disease-
free" women can be calculated by sub-
tracting these from the total expected
number for any given period. The latter
will be calculated from published rates for
the equivalent period, adjusted using the
past rates for the districts.
The findings of Shapiro's study (1978)
suggest that any effect of early detection
on mortality will not become evident
until the third year after introduction of
the programme. Using national incidence
and survival data for 1971-73 (Office of
Population Censuses, 1971) a rough esti-
mate of the expected mortality rate in an
initially disease-free cohort for Years 3-7
of the trial can be made, and used to cal-
culate the change in rate in the early-
detection districts needed to be significant
at the 50 level. This varies from 31%
to 22% for a 2-tailed test, depending on
the size of the district, but if the 2 screen-
ing districts and the 2 self-examination
districts are combined, the necessary
change in rate becomes 22% and 18%
respectively. These calculations are
approximate, and do not take into account
either differences between the rates in
individual districts and the national rate,
or additional information which will be
available from women entering the popu-
lation during the course of the trial.
XDD)ITIONAL ASPECTS OF THE TRIAL
Histopathology
The importance of comparability of
diagnosis between each of the 8 centres
was recognized, and a panel of histo-
pathologists participating in the trial was
therefore set up. The purposes of this
panel are to develop an agreed common
nomenclature for classifying the histology
of benign and malignant breast tumours;
to work towards consistency of reporting
by regular reviews of certain categories of
histology from women in the trial, and to
study the natural history and prognostic
significance ofcertain histological features.
W'ornen's attitudes towards early-detection
services
If screening or self-examination educa-
tion services are to make any sizeable
impact on breast-cancer mortality, it is
essential that they should be accepted and
practised by the great majority of women
at risk. Acceptance is influenced by
women's beliefs about the causes, treat-
ment and curability of breast cancer and
their own vulnerability. The early-detec-
tion measure must be as convenient and
pleasant as possible and, most import-
antly, must not engender undue anxiety.
Sample survevs of these aspects are being
conducted.
Radiation risks of mammography
The 2 screening centres and I self-
examination centre are using film-screen
nmammography which givesanaverageskin
exposure around 0-2 rad. The remaining
self-examination centre, which is using
xerography with a tungsten target, gives
an average skin exposure of 1 rad. A stan-
dardized measurement of dose is made
regularly in each of the early-detection
centres by a physics department inde-
pendent of the trial centres.
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Economtc assessment
It is hoped to incorporate an economic
assessment of the early-detection pro-
grammes after 2-3 years, when they are
fully operational. This will compare the
economic consequences of an early-detec-
tion policy with those of management of
breast disease in the comparison centres,
taking into account all follow-up costs
arising from early detection.
Studies of aetiology of breast cancer and
other diseases
The prospective follow-up of a cohort of
middle-aged women with subsequent noti-
fication of incidence of breast cancer and
mortality from all causes, offers an
opportunity for a prospective study of
various aetiological factors. Discussions
are now in progress about questions or
tests which might be administered to
supposedly well women entering the trial,
which might throw additional light on the
causation of breast cancer or other
diseases.
Collection of the large volume of clerical and
clinical information required for this trial is made
possible by the enthusiasm and dedication of a
multidisciplinary team of doctors, nurses, radi-
ographers, administrative, and especially secre-
tarial, clerical, programming and computing staff,
working in each of the 8 participating districts and
the coordinating centre.
The trial as a whole is supported by grants from
the Department of Health and Social Security and
the Scottish Home and Health Department. The
Cancer Research Campaign has contributed the
additional costs of setting up and recording the
effects of the breast-cancer education campaign in
Centre A, and the Helen Garrod Breast Cancer
Trust has contributed the costs of breast self-
examination education and clinic facilities in the
adjacent health district in Centre D. The Review
Panel on Breast Tumour Pathology is supported by
the Medical Research Council.
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